Novel and Emerging Approaches to Melanoma Management: Perspectives for the Community Clinician

This series of 4 podcasts will include discussions with expert leaders in melanoma. The content will focus on evaluating the use of immune checkpoint inhibitors in Stage II, Stage III, and Stage IV melanoma, understanding and overcoming resistance to anti- programmed cell death protein 1 (PD-1) immunotherapy, advances in the treatment and outcomes of patients with brain metastases, and the use of adjuvant and neoadjuvant treatment approaches.

Expert Opinion: Use of Adjuvant and Neoadjuvant Approaches in Patients With Stage III Melanoma

Dr Davies hosts Dr Mitchell on Podcast #4 to discuss adjuvant and neoadjuvant treatment approaches for patients with melanoma. Credit available for this activity expires: 9/23/2023  Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/980272?src=mkm_podcast_addon_980272

09-23
15:50

Advances in the Treatments and Outcomes for Patients With Melanoma With Brain Metastases

Dr Davies hosts Dr Tawbi in a podcast focused on treatments for patients with melanoma with brain metastases.   Credit available for this activity expires: [09/14/23] Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/980050?src=mkm_podcast_series_980050

09-14
14:57

Understanding and Overcoming Resistance to Anti-PD-1 Immunotherapy in Melanoma

Michael Davies hosts a series of 4 podcasts with leading experts to discuss important topics in melanoma.  Credit available for this activity expires: 08/31/23 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/979092?src=mkm_podcast_series_979092

08-31
13:58

Evaluating the Use of Immune Checkpoint Inhibitors in Melanoma

Dr Davies hosts Dr Postow on Podcast #1 to discuss immune checkpoint inhibitors (ICIs) for melanoma patients. Credit available for this activity expires: 8/17/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/978920?src=mkm_podcast_series_978920

08-19
14:31

Recommend Channels